Impact of Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy on Endogenous Fibrinolysis in Acute Coronary Syndrome: The VaLiDate-R study

Ying X. Gue, Vassilios Memtsas, Rahim Kanji, David Wellsted, Amanda Busby, Megan Smith, Enric Vilar, Alisdair Ryding, Deepa J. Arachchillage, Diana Gorog

Research output: Contribution to journal › Article › peer-review

73 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Impact of Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy on Endogenous Fibrinolysis in Acute Coronary Syndrome: The VaLiDate-R study'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science